Umit Tapan1, Shin Yin Lee1, Janice Weinberg2, Vijaya B Kolachalama3, Jean Francis3, Marjory Charlot1, Kevan Hartshorn1, Vipul Chitalia4. 1. Hematology-Oncology Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. 2. Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA. 3. Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. 4. Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: vichital@bu.edu.
Abstract
BACKGROUND: While racial disparity in colorectal cancer survival have previously been studied, whether this disparity exists in patients with metastatic colorectal cancer receiving care at safety net hospitals (and therefore of similar socioeconomic status) is poorly understood. METHODS: We examined racial differences in survival in a cohort of patients with stage IV colorectal cancer treated at the largest safety net hospital in the New England region, which serves a population with a majority (65%) of non-Caucasian patients. Data was extracted from the hospital's electronic medical record. Survival differences among different racial and ethnic groups were examined graphically using Kaplan-Meier analysis. A univariate cox proportional hazards model and a multivariable adjusted model were generated. RESULTS: Black patients had significantly lower overall survival compared to White patients, with median overall survival of 1.9 years and 2.5 years respectively. In a multivariate analysis, Black race posed a significant hazard (HR 1.70, CI 1.01-2.90, p=0.0467) for death. Though response to therapy emerged as a strong predictor of survival (HR=0.4, CI=0.2-0.7, p=0.0021), it was comparable between Blacks and Whites. CONCLUSIONS: Despite presumed equal access to healthcare and socioeconomic status within a safety-net hospital system, our results reinforce findings from previous studies showing lower colorectal cancer survival in Black patients, and also point to the importance of investigating other factors such as genetic and pathologic differences.
BACKGROUND: While racial disparity in colorectal cancer survival have previously been studied, whether this disparity exists in patients with metastatic colorectal cancer receiving care at safety net hospitals (and therefore of similar socioeconomic status) is poorly understood. METHODS: We examined racial differences in survival in a cohort of patients with stage IV colorectal cancer treated at the largest safety net hospital in the New England region, which serves a population with a majority (65%) of non-Caucasian patients. Data was extracted from the hospital's electronic medical record. Survival differences among different racial and ethnic groups were examined graphically using Kaplan-Meier analysis. A univariate cox proportional hazards model and a multivariable adjusted model were generated. RESULTS: Black patients had significantly lower overall survival compared to White patients, with median overall survival of 1.9 years and 2.5 years respectively. In a multivariate analysis, Black race posed a significant hazard (HR 1.70, CI 1.01-2.90, p=0.0467) for death. Though response to therapy emerged as a strong predictor of survival (HR=0.4, CI=0.2-0.7, p=0.0021), it was comparable between Blacks and Whites. CONCLUSIONS: Despite presumed equal access to healthcare and socioeconomic status within a safety-net hospital system, our results reinforce findings from previous studies showing lower colorectal cancer survival in Black patients, and also point to the importance of investigating other factors such as genetic and pathologic differences.
Authors: Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello Journal: J Clin Oncol Date: 2011-04-18 Impact factor: 44.544
Authors: Harry H Yoon; Qian Shi; Steven R Alberts; Richard M Goldberg; Stephen N Thibodeau; Daniel J Sargent; Frank A Sinicrope Journal: J Natl Cancer Inst Date: 2015-07-09 Impact factor: 13.506
Authors: Kristin Wallace; Katherine R Sterba; Elena Gore; David N Lewin; Marvella E Ford; Melanie B Thomas; Anthony J Alberg Journal: Clin Colorectal Cancer Date: 2013-12 Impact factor: 4.481
Authors: Richard M Hoffman; David K Espey; Robert L Rhyne; Melissa Gonzales; Ashwani Rajput; Shiraz I Mishra; S Noell Stone; Charles L Wiggins Journal: J Cancer Epidemiol Date: 2014-01-02
Authors: Paulina Czajka-Francuz; Tomasz Francuz; Sylwia Cisoń-Jurek; Aleksander Czajka; Marcin Fajkis; Bożena Szymczak; Maciej Kozaczka; Krzysztof Piotr Malinowski; Wojciech Zasada; Jerzy Wojnar; Jerzy Chudek Journal: Rep Pract Oncol Radiother Date: 2020-08-21
Authors: Benjamin D Fangman; Suleyman Y Goksu; Nivan Chowattukunnel; Muhammad S Beg; Nina N Sanford; Aravind Sanjeevaiah; John Cox; Michael R Folkert; Todd A Aguilera; Joselin Mathews; Javier Salgado Pogacnik; Gaurav Khatri; Craig Olson; Patricio M Polanco; Udit Verma; David Hsiehchen; Amy Jones; Radhika Kainthla; Syed M Kazmi Journal: JCO Oncol Pract Date: 2021-01-11